Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / DAILY S&P BIOTEC
-
Total 13F shares
-
411,763
-
Share change
-
+285,993
-
Total reported value
-
$16,627,782
-
Put/Call ratio
-
6%
-
Price per share
-
$40.44
-
Number of holders
-
18
-
Value change
-
+$11,564,747
-
Number of buys
-
17
Institutional Holders of DIREXION SHS ETF TR - DAILY S&P BIOTEC (LABD) as of Q3 2025
As of 30 Sep 2025,
DIREXION SHS ETF TR - DAILY S&P BIOTEC (LABD) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
411,763 shares.
The largest 10 holders included
BNP PARIBAS FINANCIAL MARKETS, Ikarian Capital, LLC, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Qube Research & Technologies Ltd, BOOTHBAY FUND MANAGEMENT, LLC, Tower Research Capital LLC (TRC), Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, and Scientech Research LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.